Best Pharmaceutical Shares For Income Investors
The main hurdle facing pharmaceutical stocks right now is patent expirations on some big-name prescription drugs. Investors worry these companies won't be able to turn out new drugs quickly enough to maintain high margins. However, many of these expirations are years away. In the meantime, the big pharmaceutical companies are stepping up merger activity, particularly in the biotech sector, and acquiring new blockbuster drugs. Also, even if some medicines lose patent protection, the larger drug companies would still have many other products that generate billions of dollars in sales, and plenty of cash to cover future dividend payments.
Here are the pharmaceutical shares with dividend yield figures:
Johnson & Johnson (NYSE:JNJ)
Novartis AG (NYSE: NVS)
Pfizer Inc. (NYSE: PFE)
Abbot Laboratories (NYSE: ABT)
Related Stock Ticker:
JNJ, NVS, PFE, ABT
If you feel that my work has helped you and you'd like to support my mission to spread investment ideas like honesty, openness, unconditional love, and courage, please make a donation below. I'm very grateful for your support.
Being supported by my readers enables me to give my creative output (articles, pdf free downloads) to the public domain, so it isn't copyrighted. Please share it freely so that others may benefit from it.
Thanks so much for your support. I really appreciate it.
To donate via PayPal, credit card, or e-check, please click the button below: